Findings The HIV/AIDS (Prevention and Control) Act, 2017 has certain lacunas or shortcomings. At one place the Act tried to recognize lot of rights to HIV/AIDS patients but on other hand the contentious clause ‘as far as possible” [ ] dilutes it from being legal right as it only obliges the government to take measure to provide the services as to diagnostic facilities, ART therapy and opportunistic, clearly indicating that it does not make this available to people as a matter of right. Section 46(2)(e) provides that the State may lay down guidelines for providing such treatment, thus leaving the entitlement completely in the hands of executive authorities thereby further, defeating the purpose of universal precautions. [ ] The insurance industry is allowed to use actuarial calculations to limit access to products to people with HIV.[ ] Though the Act provides for the grievance redressal mechanism, the wordings used “in such manner and within such time as may be prescribed” further dilutes the objective with which the Act is introduced, as it defeats the whole purpose of the Act by not prescribing procedure and time frame for disposal of complaints.[ ] The Act passed by the Parliament actually fails to bring a longevity and sustainability considering the basic demands of the HIV/AIDS patients/victims. Provisions of chapter V, VI and VII wherein powers of establishments, central and state government to take measures shows how in terms of availability and accessibility the Act fails to improve or strengthen the existing mechanism. The Act promises free ART treatment, however at the backdrop of severe budget cut by UN on funding for HIV/AIDS programmes, it clearly seems a distant dream as it has severely affected the availability of the drugs, kits, etc. [ ]Although free antiretroviral treatment, or ART, has been provided in India since 2004, the uptake remains low. Further, these clinics are neither easily accessible nor economically, physically or informationally available, has added to the complications. [ ] The General Assembly of United Nations, recalling and reaffirming its commitments on HIV/AIDS, has adopted the Declaration of Commitment on HIV/AIDS (2001) to address the problems of HIV/AIDS in all its
We have been aware of HIV and AIDS since the 1970s (Miller, 2012), and though there have been treatments and reduction in the number of people infected, the disease remains. The disease results in death usually following opportunistic infections as a result of AIDS destruction of the immune system, but thanks to modern medicine “many people
AIDS or acquired immune deficiency syndrome is a disease where a person regardless of race or gender can get infected and have no chance of survival. AIDS started in the 1980’s to move from human to human. In a event were sex kills this is the one. In 1995, AIDS was the leading cause of death for adults 25 to 44 years old. But in recent years treatments help the survival and prolonged life of many with AIDS yet the disease still resides within them and they are dangerous to the well being of
As have been described above, HIV can have a potential effect on immunological cells, which are important to protect the body from additional infections such as Tuberculosis (TB), Cytomegalovirus (CMV) and other viral or bacterial infections. An effective treatment is needed to reconstruct what HIV has damaged. Antiretroviral therapy (ART) is a common treatment to stop the viral replication and decrease the disease progression, which may lead to a vast decline of the morbidity and mortality. The standard treatment involves a combination of at least three drugs; often known as a highly active antiretroviral therapy (HAART) where the most common types are Nucleoside reverse transcriptase
Since the first occurrence of an HIV/AIDS case in Australia in 1982, Australia has been responding proactively to come up with preventative methods and treatments for the illness. Over the last ten years, we have committed over $600 million
Though the disease is still infecting many, new technology and medical techniques that include medication have made it possible to live a normal life after being infected with the HIV virus. Doctors are now far past the era in which they would deny care to an HIV-positive patient and that is because they are aware of the disease and are not afraid. Being afraid of something can unknowingly turn a person into a monster. Since being educated doctors and other healthcare professionals have been able to turn a new leaf and hop over to the supporting side of AIDS. Other than being under a doctor’s care, successful strategies for combating AIDS include “increasing awareness about prevention strategies such as using clean needles and condoms and, most recently, promoting male circumcision” (Conley 442). All these biological measures combating the chemical nature of AIDS work hand in hand to reform the social structure of the disease. Those living with AIDS in the United States today are not looked at as if they are lepers, instead they are view as survivors and
Human immunodeficiency virus (HIV)/AIDS is a pandemic problem affecting global health. At the end of 2015, 36.7 million people were living with HIV/AIDS globally. The rate of incidence is more prevalent in Sub-Saharan Africa with almost 1 in every 24 adults living with HIV/AIDS. In the united states, HIV/AIDS is a diversified health problem affecting all sexes, ages and races and involving the transmission of multiple risk behavior. However, with the introduction of various prevention programs and antiretroviral drugs, the incidence of HIV/AIDS has reduced.
The criminalization of HIV transmission has sparked many debates on how the law and health policy are related and how they both have a profound impact on health. HIV criminalization was a policy meant to incapacitate and rehabilitate those transmitting the disease to others while the retribution of the act would deter others from engaging in transmission . However, the harsh realities of criminalization have caused many to reconsider its original purpose. The criminalization of HIV transmission in Canada has negative implications on health. This paper will argue that by criminalizing HIV transmission there is a greater chance of individuals not getting tested, that living with HIV can be extremely difficult within the criminal justice system, and that criminalization does not address broader, structural issues that cause HIV transmission.
“The HIV treatment community sees the act as a critical step in our fight against the AIDS
Bradley, et al. (2014) examined the continuum of services among persons living with HIV in the United States during 2011. Data was gathered and examined from the National HIV Surveillance System (NHSS) from the United States regarding improving the care and treatment of individuals diagnosed with HIV from 2011-2013. This data was significant because the finding could ultimately assist the government with reducing new infection and related illnesses and improving the rate of viral load suppression with the assistance of antiretroviral therapy (ART). According to the authors in 2011 in the United States an estimated 1.2 million individuals were living with HIV (Bradley, et al., 2014, p. 1113). Furthermore, the authors also stated
Due to the emphasis on these three measures supporting the HIV Care Continuum, grantees have seen results with over half of the reported data 80% or above. Among these three measures, 24 out of 38 grantees reported data above 90% for prescribing ART to patients. While a similar number of grantees reported data for these three measures, more grantees were successful in prescribing ART compared to viral
Introduction –HIV, Human immune deficiency virus which started in late mid 90s has already devastated many people causing great economic impact on their families, communities and health care systems. In USA the first HIV patient was diagnosed in 1981 after which disease spreads rapidly by which it affects nearly 1.2 million people as of now. As per US centre for disease control and prevention Out of 1.2 million
Just as clearly, experience shows that the right approaches, applied quickly enough with courage and resolve, can and do result in lower HIV infection rates and less suffering for those affected by the epidemic. An ever-growing AIDS epidemic is not inevitable; yet, unless action against the epidemic is scaled up drastically, the damage already done will seem minor compared with what lies ahead. This may sound dramatic, but it is hard to play down the effects of a disease that stands to kill more than half of the young adults in the countries where it has its firmest hold—most of them before they finish the work of caring for their children or providing for their elderly parents. Already, 18.8 million people around the world have died of AIDS, 3.8 million of them children. Nearly twice that many—34.3 million—are now living with HIV, the virus [9].
Another major health policy that India just passed and adopted from the World Health Organization (WHO) is the "Test and Treat Policy for HIV". India has the third largest HIV epidemic in the world and with WHO, India wants to reduce the number people infected with HIV. Currently, 2.1 million are living in HIV in India and 86000 new cases are reported yearly. “The epidemic is concentrated among key affected populations such as sex workers. The vulnerabilities that drive the epidemic are different in different parts of the country.4 the five states with the highest HIV prevalence (Manipur, Mizoram, Nagaland, Andhra Pradesh and Karnataka) are in the south or east of the country.” ("HIV and AIDS in India", 2017) The new policy allows people to get tested and get the necessary treatment. This policy applies to everyone from all men, women, adolescents and children. This policy will greatly increase the longevity and provide a better quality of life for those ill and hopefully prevent other diseases like Tuberculosis, which
A number of African countries have been the worst hit by the spective of AIDS. CIPLA an Indian Pharmaceutical Company has offered to market ant aids medicine at one length the cost at which it is sold by global pharmaceutical firm. However due to the product patent, law, substantial controversy has been generated around the globe on ethical grounds
Forging of safer sexual behaviors through communications strategies on the general population using numerous channels, eg) Counseling, books and media.